Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Connors

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Toxicology in Vitro : an International Journal Published in Association with BIBRA|June 16, 2009
Multiplexed assay panel of cytotoxicity in HK-2 cells for detection of renal proximal tubule injury potential of compoundsYang Wu, David Connors, Lauren Barber, et al.
Assay and Drug Development Technologies|June 18, 2009
Multiplexing a high-throughput liability assay to leverage efficienciesJohn Herbst, Monique Anthony, Jeremy Stewart, et al.
Antimicrobial Agents and Chemotherapy|September 2, 2009
Inhibition of envelope-mediated CD4+-T-cell depletion by human immunodeficiency virus attachment inhibitorsLouis Alexander, Sharon Zhang, Brian McAuliffe, et al.
Journal of Biomolecular Screening|January 30, 2007
Use of cryopreserved transiently transfected cells in high-throughput pregnane X receptor transactivation assayZhengrong Zhu, Jaime Puglisi, David Connors, et al.
Assay and Drug Development Technologies|December 30, 2025
Building a State-of-the-Art Automation Platform to Support High-Throughput 96-Well Caco-2 Permeability AssayXianmei Cai, Gregory Barker, Shivani Patel, et al.
The Lancet. Infectious Diseases|April 15, 2018
Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptionsNicolas A Menzies, Emory Wolf, David Connors, et al.
Analytical Chemistry|August 21, 2025
An Ultra-High Throughput Cell-Based Mass Spectrometry Flux Assay as a Pathway-Selective In Situ Screening ApproachDaniel P Downes, Christopher M Barbieri, David Connors, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Toxicology in Vitro : an International Journal Published in Association with BIBRA|June 16, 2009
Multiplexed assay panel of cytotoxicity in HK-2 cells for detection of renal proximal tubule injury potential of compoundsYang Wu, David Connors, Lauren Barber, et al.
Assay and Drug Development Technologies|June 18, 2009
Multiplexing a high-throughput liability assay to leverage efficienciesJohn Herbst, Monique Anthony, Jeremy Stewart, et al.
Antimicrobial Agents and Chemotherapy|September 2, 2009
Inhibition of envelope-mediated CD4+-T-cell depletion by human immunodeficiency virus attachment inhibitorsLouis Alexander, Sharon Zhang, Brian McAuliffe, et al.
Journal of Biomolecular Screening|January 30, 2007
Use of cryopreserved transiently transfected cells in high-throughput pregnane X receptor transactivation assayZhengrong Zhu, Jaime Puglisi, David Connors, et al.
Assay and Drug Development Technologies|December 30, 2025
Building a State-of-the-Art Automation Platform to Support High-Throughput 96-Well Caco-2 Permeability AssayXianmei Cai, Gregory Barker, Shivani Patel, et al.
The Lancet. Infectious Diseases|April 15, 2018
Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptionsNicolas A Menzies, Emory Wolf, David Connors, et al.
Analytical Chemistry|August 21, 2025
An Ultra-High Throughput Cell-Based Mass Spectrometry Flux Assay as a Pathway-Selective In Situ Screening ApproachDaniel P Downes, Christopher M Barbieri, David Connors, et al.
Pageof 1